Trinity Biotech Reiterates Guidance To Achieve 2024 Sales Revenue For TrinScreen HIV Of Approximately $10M Trinity Biotech Reiterates Guidance To Achieve $20M Of Annualized Run-rate EBITDASO On ...
2-Year U.S. Treasury Note Continuous Contract $102.664 0.012 0.01% 5-Year U.S. Treasury Note Continuous Contract $106.648 0.063 0.06% 10-Year U.S. Treasury Note Continuous Contract $109.625 0.094 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback